MQS Management LLC purchased a new stake in shares of Bath & Body Works, Inc. (NYSE:BBWI – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 7,540 shares of the company’s stock, valued at approximately $241,000.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Envestnet Portfolio Solutions Inc. increased its holdings in Bath & Body Works by 5.2% in the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 5,571 shares of the company’s stock worth $279,000 after acquiring an additional 277 shares in the last quarter. CWM LLC increased its holdings in Bath & Body Works by 6.6% in the 2nd quarter. CWM LLC now owns 5,072 shares of the company’s stock worth $198,000 after acquiring an additional 314 shares in the last quarter. Northwest Bank & Trust Co increased its holdings in Bath & Body Works by 2.5% in the 1st quarter. Northwest Bank & Trust Co now owns 13,094 shares of the company’s stock worth $655,000 after acquiring an additional 315 shares in the last quarter. DekaBank Deutsche Girozentrale boosted its stake in Bath & Body Works by 1.0% in the 1st quarter. DekaBank Deutsche Girozentrale now owns 31,797 shares of the company’s stock worth $1,560,000 after purchasing an additional 322 shares during the period. Finally, Citizens & Northern Corp boosted its stake in Bath & Body Works by 1.7% in the 2nd quarter. Citizens & Northern Corp now owns 29,465 shares of the company’s stock worth $1,151,000 after purchasing an additional 487 shares during the period. Hedge funds and other institutional investors own 95.14% of the company’s stock.
Wall Street Analyst Weigh In
Several research firms have weighed in on BBWI. Raymond James dropped their price target on Bath & Body Works from $51.00 to $42.00 and set an “outperform” rating for the company in a research note on Thursday, August 29th. JPMorgan Chase & Co. dropped their price target on Bath & Body Works from $42.00 to $39.00 and set a “neutral” rating for the company in a research note on Thursday, August 29th. Robert W. Baird dropped their price target on Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating for the company in a research note on Thursday, August 29th. Citigroup lowered their target price on Bath & Body Works from $48.00 to $35.00 and set a “neutral” rating for the company in a research report on Tuesday, August 20th. Finally, The Goldman Sachs Group lowered their target price on Bath & Body Works from $60.00 to $49.00 and set a “buy” rating for the company in a research report on Thursday, August 29th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat.com, Bath & Body Works currently has a consensus rating of “Moderate Buy” and a consensus price target of $42.44.
Bath & Body Works Stock Up 0.7 %
Shares of BBWI opened at $31.54 on Friday. The company has a market cap of $6.91 billion, a PE ratio of 7.64, a P/E/G ratio of 1.00 and a beta of 1.79. The business has a fifty day moving average of $30.18 and a 200 day moving average of $36.49. Bath & Body Works, Inc. has a 52-week low of $26.20 and a 52-week high of $52.99.
Bath & Body Works (NYSE:BBWI – Get Free Report) last released its earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share for the quarter, topping analysts’ consensus estimates of $0.35 by $0.02. Bath & Body Works had a negative return on equity of 41.94% and a net margin of 12.69%. The business had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.54 billion. As a group, research analysts anticipate that Bath & Body Works, Inc. will post 3.18 earnings per share for the current fiscal year.
Bath & Body Works Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Friday, November 22nd will be paid a $0.20 dividend. The ex-dividend date is Friday, November 22nd. This represents a $0.80 dividend on an annualized basis and a yield of 2.54%. Bath & Body Works’s payout ratio is 19.37%.
Insiders Place Their Bets
In other news, CEO Gina Boswell purchased 6,000 shares of the business’s stock in a transaction dated Wednesday, October 9th. The shares were purchased at an average price of $29.64 per share, for a total transaction of $177,840.00. Following the completion of the purchase, the chief executive officer now owns 242,987 shares in the company, valued at approximately $7,202,134.68. This represents a 2.53 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 0.27% of the company’s stock.
About Bath & Body Works
Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.
Featured Stories
- Five stocks we like better than Bath & Body Works
- Ride Out The Recession With These Dividend KingsĀ
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- What is an Earnings Surprise?
- Top-Performing Non-Leveraged ETFs This Year
- Why Are Stock Sectors Important to Successful Investing?
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI – Free Report).
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.